Dr. Reddy's Laboratories Limited (RDY) has a market capitalization of $10.93B and trades at $13.13. The 52-week range is 12.26-16.17.
Key metrics include annual revenue of $325.54B.
The stock has a beta of 0.30, a last dividend of $0.0915, operates in the Healthcare sector.